Evidence map›Paper›PMID 31806997›Full record

ArticleOncoTargets and therapy2019

Expression And Biological Interaction Network Of RHOC For Hepatic Carcinoma With Metastasis In PBMC Samples.

Yanting Shen, Lu Bu, Rui Li, Zhenzhu Chen, Fei Tian, Qinyu Ge

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Research progress in myosin light chain 9 in malignant tumors.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yanting ShenDepartment of Science and Education, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, People's Republic of China.
Lu BuDepartment of Interventional Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing 210009, People's Republic of China.
Rui LiState Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, People's Republic of China.
Zhenzhu ChenState Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, People's Republic of China.
Fei TianState Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, People's Republic of China.
Qinyu GeState Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, People's Republic of China.ORCID 0000-0002-1708-1949
State Key Laboratory of Digital Medical EngineeringFudan University · CNZhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHepatic carcinoma with metastasis remains incurable, and clinical diagnostic methods lacked adequate sensitivity and specificity. Therefore, seeking effectively diagnostic biomarkers is still essential for it.

methodsPBMC samples were isolated. Then, RNA-seq was performed to identify the DEGs between hepatic carcinoma with metastasis and hepatic carcinoma with solitary tumor. Subsequently, q-RT-PCR was used to verify the expression level of

resultsThe results of both RNA-seq and q-RT-PCR showed that the expression level of

conclusionOur results indicated that

Indexed as

diagnosishepatic carcinomametastasisPBMCRHOC

Identifiers

PMID31806997
PMCPMC6842290
OpenAlexW2984909178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.